rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2006-5-25
|
pubmed:abstractText |
To compare cell proliferation markers, minichromosome maintenance protein 2 (MCM2) and Ki67, in minimally invasive follicular carcinoma (MIFC) and follicular adenoma (FA) of the thyroid and among MIFCs with different diagnostic criteria.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0309-0167
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
801-7
|
pubmed:dateRevised |
2007-6-29
|
pubmed:meshHeading |
pubmed-meshheading:16722928-Adenocarcinoma, Follicular,
pubmed-meshheading:16722928-Adenoma,
pubmed-meshheading:16722928-Cell Cycle Proteins,
pubmed-meshheading:16722928-Cell Proliferation,
pubmed-meshheading:16722928-Diagnosis, Differential,
pubmed-meshheading:16722928-Humans,
pubmed-meshheading:16722928-Immunohistochemistry,
pubmed-meshheading:16722928-Ki-67 Antigen,
pubmed-meshheading:16722928-Nuclear Proteins,
pubmed-meshheading:16722928-Thyroid Neoplasms
|
pubmed:year |
2006
|
pubmed:articleTitle |
Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid.
|
pubmed:affiliation |
Department of Pathology, Nagoya City University Medical School, Nagoya, Japan.
|
pubmed:publicationType |
Journal Article
|